Investment process: Research-driven and growth-focused
JPGI manager Jeroen Huysinga, who joined JPMAM in 1997, is a member of the global focus fund investment team, which has six portfolio managers as well as the large team of analysts. Huysinga also manages the firm’s Global Focus SICAV, which follows the same strategy as JPGI.
Using the dividend discount model described above, JPMAM is able to rank companies by their long-term value as measured by the DDR. On a sector-by-sector basis (to allow for like-for-like comparisons), stocks in the global equity universe are split into quintiles, from the cheapest to the most expensive. There are 17 sectors, grouped under the broad headings of financials, healthcare, consumer, TMT (telecom, media and technology) and industrials. For the JPGI portfolio Huysinga focuses on stocks in the cheapest two quintiles, although because the analysts cover the whole universe, the manager may also look at companies in more expensive quintiles that could become candidates for investment should their valuations change.
The portfolio is constructed on the basis of four variables: valuation; significant profit potential; catalysts; and time horizon. As well as a valuation in the top two cheapest quintiles, a company must be assessed as having at least 25% profit growth potential from current to normalised earnings per share. Applying these two tests filters the universe of 2,500 stocks down to c 500.
The next step is to define an identifiable trigger for a reappraisal of a company’s earnings potential, which would bring the consensus market view more into line with JPMAM’s assessment and thus lead to a rise in the share price. Catalysts are company-specific factors that may include restructuring, a new management team or a company expanding into new markets. Such a catalyst should occur within the next six to 18 months, although given that stocks are assessed on their long-term earnings potential, they may stay in the portfolio for much longer than this. Applying these two criteria brings the universe down to c 50-90 stocks, which form the basis of the JPGI portfolio. All stocks must tick all four boxes to be included.
Initial positions are sized at c 0.5-1.5 percentage points above their index weight. The size of a position is based not just on the strength of the valuation signal but also the number of catalysts, the timeline for their achievement, perceived risk and liquidity.
The manager aims for a broad spread of country and sector exposures, although sector-specific factors may affect the number of stocks that make it through the screens. For example, utilities (a sector where JPGI has no exposure) is a low-growth area, so it is hard to find companies with 25% upside to normalised earnings. On the other hand, the trust is overweight the index in industrial cyclicals, where there is more unpredictability in earnings potential. The portfolio contains both bigger and smaller stocks, although the manager notes that mega-cap exposure tends to be below the index level, given there is better earnings growth potential among mid-cap stocks.
With the universe of potential investments being reassessed constantly by the analyst team, there is a strong sell discipline, and the manager will revisit the entire investment case for a stock when one price driver is no longer valid. Where a stock has performed well and its valuation is no longer in the two cheapest quintiles, the manager notes that he will normally sell and switch into something cheaper.
Current portfolio positioning
At 31 July 2016 (the latest date for which full portfolio information was available), JPGI had 77 holdings, with c 24% of assets invested in the top 10 holdings. This was both a longer stock list and a lower concentration in the top 10 than the majority of peers in the AIC Global Equity Income sector. However, it is worth noting that trusts in the AIC Global sector, of which JPGI was a member until the recent change in its distribution policy, have more than 100 holdings on average.
Sector exposure (Exhibit 3) is broad, although certain sectors are absent. Overweight areas include industrials and healthcare, while consumer staples – an area that has done well and where many stocks are now seen as expensive – is largely absent.
Exhibit 3: Portfolio sector exposure vs benchmark (%)
|
Portfolio end- July 2016 |
Portfolio end- July 2015 |
Change (pts) |
Index weight |
Active weight vs index (pts) |
Trust weight/ index weight |
Healthcare |
16.8 |
14.1 |
2.7 |
12.6 |
4.2 |
1.3 |
Industrial cyclicals |
9.3 |
9.5 |
-0.2 |
7.4 |
2.0 |
1.3 |
Banks |
8.0 |
12.8 |
-4.8 |
12.6 |
-4.7 |
0.6 |
Technology - semiconductors |
7.4 |
4.4 |
3.0 |
3.0 |
4.4 |
2.4 |
Insurance |
7.3 |
5.4 |
1.9 |
3.7 |
3.6 |
2.0 |
Retail |
6.4 |
7.5 |
-1.2 |
6.0 |
0.4 |
1.1 |
Transport & cons cyclical |
6.4 |
7.9 |
-1.5 |
4.5 |
1.9 |
1.4 |
Energy |
6.3 |
N/A |
N/A |
6.4 |
-0.1 |
1.0 |
Telecommunications |
6.1 |
3.6 |
2.5 |
4.7 |
1.4 |
1.3 |
Media |
5.0 |
8.3 |
-3.3 |
5.8 |
-0.8 |
0.9 |
Consumer non-durable |
4.0 |
N/A |
N/A |
8.6 |
-4.6 |
0.5 |
Others and cash |
17.1 |
26.5 |
-9.4 |
24.7 |
-7.6 |
0.7 |
|
100.0 |
100.0 |
|
100.0 |
|
|
Source: JPMorgan Global Growth & Income, Edison Investment Research
On a geographical basis (Exhibit 4), the trust is overweight the UK, continental Europe and Japan, where the manager sees better opportunities than in North America, emerging markets and developed Asia. Because the investment process is bottom-up, country weightings are incidental, although geography may have an impact on valuation. Huysinga comments that Japan’s decades of misery have caused investors to underestimate the upside potential of stocks in the market’s periodic recoveries. Currency exposure is hedged back to the benchmark (excluding emerging markets) using passive hedges, so for example, given the underweight to the US, the trust buys US dollars and sells currencies where the portfolio is overweight to achieve a neutral currency allocation.
Exhibit 4: Portfolio geographic exposure vs benchmark (%)
|
Portfolio end- July 2016 |
Index weight |
Active weight vs index (pts) |
Trust weight/ index weight |
North America** |
47.6 |
56.5 |
-8.9 |
0.8 |
Continental Europe** |
21.8 |
14.8 |
7.0 |
1.5 |
United Kingdom |
15.9 |
6.3 |
9.6 |
2.5 |
Emerging Markets |
5.0 |
10.2 |
-5.2 |
0.5 |
Japan |
9.7 |
7.8 |
2.0 |
1.3 |
Developed Asia |
0.0 |
4.5 |
-4.5 |
0.0 |
|
100.0 |
100.0 |
|
|
Source: JPMorgan Global Growth & Income, Edison Investment Research. Note: *NXP Semiconductors has been reclassified to Continental Europe from North America at 31 December 2015.
The portfolio includes some stocks that are monitored by the analyst team in spite of being outside the benchmark. The manager highlights Finnish stainless steel company Outokumpu as an example of this, commenting that as a European cyclical stock in the steel sector that has had balance sheet issues in the past, it is the antithesis of many of the trends that have been driving markets in recent years, where the focus has been on quality defensive stocks. The company has an impressive new CEO, who has been focusing the company and divesting or streamlining operations, leading to a more than 100% increase in the share price so far this year.
Other large active positions include Shire Pharmaceutical, an innovative company with a focus on rare diseases. Its recent acquisition of Baxalta was viewed with suspicion by many investors, but JPMAM healthcare analyst Anne Marden views the transaction as offering significant synergies, creating a global leader in its field with an excellent management team. While the stock has risen by c 50% since Huysinga added to it earlier this year, he notes that it still looks quite cheap relative to companies such as Johnson & Johnson and Amgen.
Bayer is another component of the healthcare overweight; Huysinga argues that weak sentiment towards Germany has led to an unjustified derating in the stock, where he still sees growth potential, boosted by the acquisition of a portfolio of over-the-counter consumer care products from US-listed Merck.